We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+5.31%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$23B
AUM Growth
-$233M
(-1%)
Cap. Flow
-$880M
Cap. Flow
% of AUM
-3.82%
Top 10 Holdings %
Top 10 Hldgs %
33.31%
Holding
1,606
New
44
Increased
614
Reduced
449
Closed
86
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$63.2M |
| 2 |
Eagle Materials
EXP
|
+$56.2M |
| 3 |
Itron
ITRI
|
+$54.4M |
| 4 |
Apple
AAPL
|
+$52.6M |
| 5 |
Enphase Energy
ENPH
|
+$40.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cooper Companies
COO
|
+$82.8M |
| 2 |
NVIDIA
NVDA
|
+$76M |
| 3 |
Microsoft
MSFT
|
+$62.6M |
| 4 |
Adobe
ADBE
|
+$62.2M |
| 5 |
Jabil
JBL
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.79% |
| 2 | Healthcare | 19.28% |
| 3 | Financials | 10.14% |
| 4 | Communication Services | 9.05% |
| 5 | Industrials | 8.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Park National Corp
PRK
$3.75B
| $422K | ﹤0.01% |
2,965
| – | – |
|
1227
LiveRamp
RAMP
$2.31B
| $420K | ﹤0.01% |
13,567
| – | – |
|
1228
Vera Therapeutics
VERA
$2.08B
| $420K | ﹤0.01% |
+11,600
| New | +$460K |
|
1229
Progress Software
PRGS
$1.83B
| $419K | ﹤0.01% |
7,716
| – | – |
|
1230
Gibraltar Industries
ROCK
$1.45B
| $419K | ﹤0.01% |
6,109
| – | – |
|
|
AKRO
1231
DELISTED
Akero Therapeutics
AKRO
| $418K | ﹤0.01% |
17,800
+8,000
| +82% | +$171K |
|
1232
MasterBrand
MBC
$1.89B
| $418K | ﹤0.01% |
28,500
| – | – |
|
1233
Simmons First National
SFNC
$3.46B
| $418K | ﹤0.01% |
23,760
+800
| +3% | +$14.1K |
|
1234
United Parks & Resorts
PRKS
$2.04B
| $418K | ﹤0.01% |
7,700
-4,700
| -38% | -$246K |
|
1235
Eastern Bankshares
EBC
$5.37B
| $417K | ﹤0.01% |
29,800
+900
| +3% | +$12K |
|
1236
First Merchants
FRME
$2.72B
| $417K | ﹤0.01% |
12,516
-1,000
| -7% | -$33.4K |
|
1237
ePlus
PLUS
$2.31B
| $416K | ﹤0.01% |
5,644
| – | – |
|
1238
Celldex Therapeutics
CLDX
$3.35B
| $415K | ﹤0.01% |
11,200
+3,100
| +38% | +$117K |
|
1239
CoreCivic
CXW
$3.13B
| $414K | ﹤0.01% |
31,900
+10,600
| +50% | +$155K |
|
1240
Harmonic Inc
HLIT
$1.42B
| $414K | ﹤0.01% |
35,200
| – | – |
|
1241
Beam Therapeutics
BEAM
$2.74B
| $412K | ﹤0.01% |
17,600
+700
| +4% | +$17.2K |
|
1242
Freshworks
FRSH
$3.51B
| $409K | ﹤0.01% |
32,200
+5,600
| +21% | +$83.8K |
|
1243
Ligand Pharmaceuticals
LGND
$5.76B
| $409K | ﹤0.01% |
4,858
+1,200
| +33% | +$95.5K |
|
1244
Newmark Group
NMRK
$2.77B
| $408K | ﹤0.01% |
39,917
+3,700
| +10% | +$37.7K |
|
|
B
1245
DELISTED
Barnes Group Inc.
B
| $408K | ﹤0.01% |
9,855
-2,600
| -21% | -$98.2K |
|
1246
CorVel
CRVL
$3.25B
| $407K | ﹤0.01% |
4,800
| – | – |
|
1247
Materion
MTRN
$5.88B
| $407K | ﹤0.01% |
3,766
| – | – |
|
1248
Hillman Solutions
HLMN
$1.71B
| $406K | ﹤0.01% |
45,900
| – | – |
|
1249
Empire State Realty Trust
ESRT
$836M
| $405K | ﹤0.01% |
43,218
| – | – |
|
1250
InvenTrust Properties
IVT
$2.62B
| $404K | ﹤0.01% |
16,300
+600
| +4% | +$14.8K |
|
Similar funds
GAM
Handelsbanken Fonder's Q2 2024 Portfolio in Review
As of Q2 2024, Handelsbanken Fonder held 1,606 positions worth $23B, down 1% from $23.2B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Handelsbanken Fonder withdrew a net $880M in Q2 2024, closing 86 positions and reducing 449 holdings. Its most notable exit was Shockwave Medical, Inc. Common Stock, an estimated $20.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 33% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Handelsbanken Fonder opened a new position in Kenvue worth $12.8M.
- Handelsbanken Fonder's largest Q2 2024 buy was Kenvue: 701,911 shares worth $12.8M.
- Handelsbanken Fonder added most to Vertex Pharmaceuticals in Q2 2024, an estimated $63.2M increase.
- Handelsbanken Fonder's biggest Q2 2024 reduction was Cooper Companies, cutting an estimated $82.8M.
- Handelsbanken Fonder fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $20.6M.
- Handelsbanken Fonder's ten largest holdings make up 33% of its $23B portfolio in Q2 2024.
- Handelsbanken Fonder opened 44 new positions and closed 86 in Q2 2024.
- Handelsbanken Fonder's portfolio value fell 1% quarter-over-quarter to $23B.
Based on Handelsbanken Fonder's 13F filing for Q2 2024, filed 5 Aug 2024.